Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
Spec Care Dentist ; 38(3): 160-162, 2018 May.
Article in English | MEDLINE | ID: mdl-29645289

ABSTRACT

Leukemic infiltration of the gingival tissue associated or not with gingival enlargement may be the first manifestation of acute leukemia, despite being rarely reported in the literature. A 10-year-old female patient presented with a 1-month history of an asymptomatic, firm, and pinkish-red generalized gingival overgrowth. There was no bone resorption. Incisional biopsy of the gingival tissue was performed, with histopathological examination revealing a diffuse and hypercellular infiltration of monocytoid cells. The patient was referred to a hematologist and underwent a bone marrow biopsy, which led to a conclusive diagnosis of acute myeloid leukemia. The patient was treated with chemotherapy and we observed regression of gingival enlargement after 4 weeks from the initial therapy.


Subject(s)
Gingival Overgrowth/pathology , Leukemia, Myeloid, Acute/diagnosis , Leukemic Infiltration/pathology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Child , Female , Gingival Overgrowth/diagnostic imaging , Gingival Overgrowth/drug therapy , Humans , Leukemia, Myeloid, Acute/diagnostic imaging , Leukemia, Myeloid, Acute/drug therapy , Leukemic Infiltration/diagnostic imaging , Leukemic Infiltration/drug therapy , Radiography, Panoramic
2.
An. bras. dermatol ; An. bras. dermatol;91(5,supl.1): 72-75, Sept.-Oct. 2016. graf
Article in English | LILACS | ID: biblio-837930

ABSTRACT

Abstract Wolf's isotopic response designates the appearance of two subsequent unrelated dermatoses in the same anatomic location. We report the case of a 51-year-old man with a medical history of chronic lymphocytic leukemia without known extra-hematopoietic involvement. The patient developed a disseminated papulo-vesiculous eruption, diagnosed as varicella. Few days after recovering, an erythematous and violaceous papular dermatosis with histopathological examination compatible with leukemic infiltration appeared on the scars of previous herpetic lesions. Complete remission was obtained under systemic corticotherapy, without cutaneous recurrence or blastic transformation. Wolf's isotopic response is attributed to a localized immunologic imbalance following a certain stimulus. In this patient, herpetic infection acted as a local spur for inaugural cutaneous leukemic infiltration, with no impact on the prognosis for the underlying disease.


Subject(s)
Humans , Male , Middle Aged , Skin/pathology , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Chickenpox/pathology , Skin Diseases, Viral/pathology , Leukemic Infiltration/pathology , Immunohistochemistry , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Chickenpox/drug therapy , Treatment Outcome , Skin Diseases, Viral/drug therapy , Leukemic Infiltration/drug therapy , Dermis/pathology , Herpes Zoster/pathology
3.
An Bras Dermatol ; 91(2): 248-9, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27192532

ABSTRACT

Bullous leukemia cutis is an uncommon clinical manifestation of cutaneous infiltration by leukemic cells, from B-cell chronic lymphocytic leukemia. We present the case of a 67-year-old, female, chronic lymphocytic leukemia patient. She was taking chlorambucil and developed facial edema with erythema and warmth, misjudged as facial cellulitis. Two days later, she developed bullous lesions in the arms, legs, neck and face. The histopathology of facial and bullous lesions confirmed leukemia cutis. All lesions disappeared following the administration of rituximab combined with cycles of fludarabine and cyclophosphamide. Although soft tissue infections are common complications in patients undergoing chemotherapy, leukemia cutis can also resemble cellulitis.


Subject(s)
Cellulitis/pathology , Facial Dermatoses/pathology , Leukemia, Lymphoid/pathology , Leukemic Infiltration/pathology , Skin Diseases, Vesiculobullous/pathology , Aged , Antineoplastic Agents, Alkylating/therapeutic use , Cyclophosphamide/therapeutic use , Diagnosis, Differential , Facial Dermatoses/drug therapy , Female , Humans , Immunohistochemistry , Leukemia, Lymphoid/drug therapy , Leukemic Infiltration/drug therapy , Skin Diseases, Vesiculobullous/drug therapy
4.
An Bras Dermatol ; 91(5 suppl 1): 72-75, 2016.
Article in English | MEDLINE | ID: mdl-28300900

ABSTRACT

Wolf's isotopic response designates the appearance of two subsequent unrelated dermatoses in the same anatomic location. We report the case of a 51-year-old man with a medical history of chronic lymphocytic leukemia without known extra-hematopoietic involvement. The patient developed a disseminated papulo-vesiculous eruption, diagnosed as varicella. Few days after recovering, an erythematous and violaceous papular dermatosis with histopathological examination compatible with leukemic infiltration appeared on the scars of previous herpetic lesions. Complete remission was obtained under systemic corticotherapy, without cutaneous recurrence or blastic transformation. Wolf's isotopic response is attributed to a localized immunologic imbalance following a certain stimulus. In this patient, herpetic infection acted as a local spur for inaugural cutaneous leukemic infiltration, with no impact on the prognosis for the underlying disease.


Subject(s)
Chickenpox/pathology , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Leukemic Infiltration/pathology , Skin Diseases, Viral/pathology , Skin/pathology , Chickenpox/drug therapy , Dermis/pathology , Herpes Zoster/pathology , Humans , Immunohistochemistry , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemic Infiltration/drug therapy , Male , Middle Aged , Skin Diseases, Viral/drug therapy , Treatment Outcome
5.
Article in Spanish | MEDLINE | ID: mdl-18426096

ABSTRACT

We present a 71 year old male patient with previous records of Chronic Lymphocytic Leukaemia who presented with a tumoral skin lesion. Histological and immunohistochemical studies confirmed the Leukaemia Cutis diagnosis. The patient underwent treatment with clorambucile and systemic steroids with remision of both haemathological and skin manifestation. The patient is still under close clinical follow up and remission continues eight months so far.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Leukemic Infiltration/pathology , Skin/pathology , Aged , Antineoplastic Agents, Alkylating/therapeutic use , Biopsy , Chlorambucil/therapeutic use , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemic Infiltration/drug therapy , Male , Recurrence
6.
Rev. Fac. Cienc. Méd. (Córdoba) ; Rev. Fac. Cienc. Méd. (Córdoba);64(1): 42-44, 2007. ilus
Article in Spanish | LILACS | ID: lil-485162

ABSTRACT

Presentamos un paciente varón de 71 años con lesión tumoral en piel y antecedente de LLC. Los estudios histopatológicos y de inmunohistoquímica confirman el diagnóstico de Leucemia Cutis. Se realiza tratamiento con Clorambucilo y corticoides vía oral, remitiendo su enfermedad hematológica y cutánea. Actualmente luego de ocho meses del diagnóstico de LC, el paciente se encuentra libre de enfermedad.


We present a 71 year old male patient with previous records of Chronic Lymphocytic Leukaemia who presented with a tumoral skin lesion. Histological and immunohistochemical studies confirmed the Leukaemia Cutis diagnosis. The patient underwent treatment with clorambucile and systemic steroids with remision of both haemathological and skin manifestation. The patient is still under close clinical follow up and remission continues eight months so far.


Subject(s)
Humans , Male , Aged , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Leukemic Infiltration/pathology , Skin/pathology , Antineoplastic Agents, Alkylating/therapeutic use , Biopsy , Chlorambucil/therapeutic use , Immunohistochemistry , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemic Infiltration/drug therapy
10.
Mem. Inst. Oswaldo Cruz ; 89(1): 59-61, jan.-mar. 1994. ilus
Article in English | LILACS | ID: lil-155809

ABSTRACT

A case of a 20-years-old black man from Salvador, Bahia with HTLV-I associated T cell lymphoma is presented. In spite of the absence of splenomegaly and leukemia, the patient had a marked cephalic tumoral infiltrationassociated with axillary tumors in a pattern not yet described in adult T cell lymphoma. Peripheral blood involvement was observed later on in the course of thedisease. The patient underwent chemotherapy but died seven monts after diagnosis


Subject(s)
Humans , Male , Adult , Leukemic Infiltration/pathology , Leukemia-Lymphoma, Adult T-Cell/pathology , Skin/pathology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bleomycin/administration & dosage , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Face/pathology , Leukemic Infiltration/drug therapy , Leukemia-Lymphoma, Adult T-Cell/immunology , Leukemia-Lymphoma, Adult T-Cell/drug therapy , Prednisone/administration & dosage , Vincristine/administration & dosage
11.
Mem Inst Oswaldo Cruz ; 89(1): 59-61, 1994.
Article in English | MEDLINE | ID: mdl-7529865

ABSTRACT

A case of a 20-years-old black man from Salvador, Bahia with HTLV-I associated T cell lymphoma is presented. In spite of the absence of splenomegaly and leukemia, the patient had a marked cephalic tumoral infiltration associated with axillary tumors in a pattern not yet described in adult T cell lymphoma. Peripheral blood involvement was observed later on in the course of the disease. The patient underwent chemotherapy but died seven months after diagnosis.


Subject(s)
Leukemia-Lymphoma, Adult T-Cell/pathology , Leukemic Infiltration/pathology , Skin/pathology , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bleomycin/administration & dosage , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Face/pathology , Humans , Leukemia-Lymphoma, Adult T-Cell/drug therapy , Leukemia-Lymphoma, Adult T-Cell/immunology , Leukemic Infiltration/drug therapy , Male , Prednisone/administration & dosage , Prognosis , Vincristine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL